Peptide-nanoparticle hybrid SERS probe for dynamic detection of active cancer biomarker enzymes

Annual International Conference of the IEEE Engineering in Medicine and Biology - Proceedings

Volumn , Issue , 2006, Pages 795-798

  Liu, Gang L ^a,b   Chen, F Frank ^c   Ellman, Jonathan A ^d   Lee, Luke P ^b  

^a IEEE   (United States)

^b University of California   (United States)

^c LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMARKER ENZYMES; NANOCRESCENT PARTICLE; RADIOACTIVE PROBES;

BIOASSAY; BIOMARKERS; CONCENTRATION (PROCESS); NANOPARTICLES; PEPTIDES; TUMORS;

ENZYMES;

DIAGNOSTIC AGENT; NANOPARTICLE; PEPTIDE; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER; TUMOR PROTEIN;

ARTICLE; CHEMISTRY; GENETIC PROCEDURES; METHODOLOGY; RAMAN SPECTROMETRY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

MOLECULAR PROBE TECHNIQUES; NANOPARTICLES; NEOPLASM PROTEINS; PEPTIDES; PROSTATE-SPECIFIC ANTIGEN; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTRUM ANALYSIS, RAMAN; TUMOR MARKERS, BIOLOGICAL;

EID: 34047112368     PISSN: 05891019     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/IEMBS.2006.260259     Document Type: Conference Paper

References (23)

1. E.D. Crawford, "Epidemiology of prostate cancer," Urology 62, 2003, pp. 3-12.
2. H. Gronberg, "Prostate cancer epidemiology," Lancet 361, 2003, pp. 859-864.
3. K. J. Pienta, J. A. Goodson, and P. S. Esper, "Epidemiology of prostate cancer: molecular and environmental clues," Urology 48, 1996, pp. 676-683.
4. S. R. Denmeade and J. T. Isaacs, "A history of prostate cancer treatment," Nat Rev Cancer 2, 2002, pp. 389-396.
5. S. R. Denmeade and J. T. Isaacs, "The role of prostate-specific antigen in the clinical evaluation of prostatic disease," BJU Int 93 Suppl 1, 2004, pp. 10-15.
6. S. D. Mikolajczyk et al, "Proenzyme forms of prostate-specific antigen in serum improve the detection of prostate cancer," Clin Chem 50, 2004, pp. 1017-1025.
7. S. D. Mikolajczyk, and H. G. Rittenhouse, "Pro PSA: a more cancer specific form of prostate specific antigen for the early detection of prostate cancer," Keio J Med 52, 86-91 (2003).
8. S. D. Mikolajczyk, Y. Song, J. R.Wong, R. S. Matson, and H. G. Rittenhouse, "Are multiple markers the future of prostate cancer diagnostics?" Clin Biochem 37, 519-528 (2004).
9. P. Wu, U. H. Stenman, M. Pakkala, A. Narvanen, and J. Leinonen, "Separation of enzymatically active and inactive prostate-specific antigen (PSA) by peptide affinity chromatography," Prostate 58, 345-353 (2004).
10. P. Wu, L. Zhu, U. H. Stenman, and J. Leinonen, "Immunopeptidometric assay for enzymatically active prostate-specific antigen," Clin Chem 50, 125-129 (2004).
11. M. Brillard-Bourdet et al, "Amidolytic activity of prostatic acid phosphatase on human semenogelins and semenogelin-derived synthetic substrates," Eur J Biochem 269, 390-395 (2002).
12. S. Rehault et al, "Design of new and sensitive fluorogenic substrates for human kallikrein hK3 (prostate-specific antigen) derived from semenogelin sequences," Biochim Biophys Acta 1596, 55-62 (2002).
13. Y. Lu, G. L. Liu, J. Kim, Y. X. Mejia, and L. P. Lee, "Nanophotonic crescent moon structures with sharp edge for ultrasensitive biomolecular detection by local electromagnetic field enhancement effect," Nano Lett 5, 119-124 (2005).
14. J. Malm, J. Hellman, P. Hogg, and H. Lilja, "Enzymatic action of prostate-specific antigen (PSA or hK3): substrate specificity and regulation by Zn(2+), a tight-binding inhibitor," Prostate 45, 132-139 (2000).
15. C. V. Raman, "A change of wave-length in light scattering," Nature 121, 619-619 (1928).
16. Y. Lu, G. L. Liu, and L. P. Lee, "High-density silver nanoparticle film with temperature-controllable interparticle spacing for a tunable surface enhanced Raman scattering substrate," Nano Lett 5, 5-9 (2005).
17. A. J. Haes, L. Chang, W. L. Klein, and R. P. Van Duyne, "Detection of a biomarker for Alzheimer's disease from synthetic and clinical samples using a nanoscale optical biosensor," J Am Chem Soc 127, 2264-2271 (2005).
18. J. B. Jackson, and N. J. Halas, "Surface-enhanced Raman scattering on tunable plasmonic nanoparticle substrates," P Natl Acad Sci USA 101, 17930-17935 (2004).
19. S. Nie, and S. R. Emory, "Probing Single Molecules and Single Nanoparticles by Surface-Enhanced Raman Scattering," Science 275, 1102-1106 (1997).
20. G. L. Liu, and L. P. Lee, "Nanowell surface enhanced Raman scattering arrays fabricated by soft-lithography for lable-free biomolecular detections in integrated microfluidics," Appl. Phys. Lett. 87, 074101 (2005).
21. V.-D. Tuan, L. R. Allain, and D. L. Stokes, "Cancer gene detection using surface-enhanced Raman scattering (SERS)," J. Raman Spec. 33, 511-516(2002)
22. S. R. Denmeade et al, "Specific and efficient peptide substrates for assaying the proteolytic activity of prostate-specific antigen," Cancer Res 57, 4924-4930 (1997).
23. G. L. Liu, Y. Lu, J. Kim, J. C. Doll, and L. P. Lee, "Magnetic Nanocrescents as Controllable Surface Enhanced Raman Scattering Nanoprobes for Biomolecular Imaging," Adv. Mater, (in press).